The formula for a productive investor update email
Because so many of you asked for it!
Making sense of healthcare deals, technology, policy, and the occasional industry curveball.
Because so many of you asked for it!
Plus, some thoughts about Transcarent buying Accolade!
How I’ve been thinking about recent events
Health care VCs are flocking to AI - and it’s all starting to feel a lot like crypto
I teamed up with two health policy experts to explore the bull and bear case.
The company closed up shop abruptly this week.
Lessons learned after a strategy shift featuring Brightline CEO Naomi Allen and investor Alyssa Jaffee
That’s the question of the moment - and we explore it in-depth.
With Tom Cassels, who’s sat on plenty of boards as an independent director
I’m introducing a new series to ask experts in the space tough questions about topics of the moment
One longtime women's health investor weighs in...
Important new data is out today indicating that might be the case — and for the very reason you might expect!